chartexchange

BetterLife Pharma Announces Settlement of Claim with Dr. Steven Sangha

Newsfile | Nov 6, 2026 8:00 AM EST

- Adoption of Advance Notice Policy -- Appointment of LifeSci Advisors - Vancouver, British Columbia--(Newsfile Corp. - November 6, 2026) - BetterLife Pharma Inc.  (CSE: BETR) (OTCQB: BETRF) (FSE: NPAU) ("BetterLife" or the "Company"), a biotechnology company developing BETR-001 for chronic cluster headache and chronic migraine, today announced that it has entered into a settlement agreement dated November 5, 2026 (the "Settlement Agreement") with Dr. Steven Sangha ("Dr. Sangha"), a director of...

Read original article